Skip to content

Xencor XNCR Advance Future Royalty And Milestone Payments

Advance Future Royalty And Milestone Payments at other companies

AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$263.74M-20.2%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$12.81M-44.3%
Geron logo
GeronGERN
$0-100%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$20M
Alliance Resource Partners logo
Alliance Resource PartnersARLP
$305.5K-56.1%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$17.5M

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept xncr:AdvanceFutureRoyaltyAndMilestonePayments.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's advance future royalty and milestone payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's advance future royalty and milestone payments?
Xencor (XNCR) reported advance future royalty and milestone payments of $0 in Q1 2026.
How has Xencor's advance future royalty and milestone payments changed year-over-year?
Xencor's advance future royalty and milestone payments decreased by 100.0% year-over-year, from $1.73M to $0.
What does advance future royalty and milestone payments mean?
This metric represents cash inflows or outflows associated with the monetization of future royalty streams or milestone payments from intellectual property licensing agreements. It reflects the company's strategy of leveraging its proprietary technology platform to secure upfront capital in exchange for future revenue rights. Monitoring this figure helps investors assess the company's reliance on non-dilutive financing and the impact of these arrangements on long-term revenue recognition.